Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups
about
Helicobacter pylori genotypes influence serum pepsinogen C levelsManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuSerologic screening before endoscopy: the value of Helicobacter pylori serology, serum recognition of the CagA and VacA proteins, and serum pepsinogen I.Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication.Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.Review article: the cost of diagnosing Helicobacter pylori infection.Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori statusImportance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers.Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics.Development and analytical validation of an enzyme linked immunosorbent assay for the measurement of canine gastric lipase immunoreactivity in serum.Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology.Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori.Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.Serum nitrate/nitrite concentration correlates with gastric juice nitrate/nitrite: a possible marker for mutagenesis of the proximal stomach.Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study.Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortugRelationship among serum pepsinogens, serum gastrin, gastric mucosal histology andH. pylorivirulence factors in a paediatric population
P2860
Q28258287-6BC6F2DC-2D04-47D3-ABBE-C368CEF3F939Q30426539-F4CB7462-5936-4124-A194-1CAC59376BBAQ30482000-6C079EF4-4C47-457A-9C50-3CF02A413BB6Q33851017-4F006BA5-1EC1-4DE0-ABFF-0E9954756BBFQ34069642-98216F41-381A-49A1-B201-B27D674D11BCQ34327950-A420224B-0DDB-4E44-BD2A-B10C16197EDFQ35755917-7068F39E-67D2-42AC-966A-0EC2C9B409EFQ36013985-DCDCE404-0951-4891-9337-32F8B674DE35Q36693173-C89E409D-1D9E-481D-9081-307B02264D2DQ37355104-BA7A7058-6822-40EA-9507-706470C296D2Q42825613-9248FE7A-3A83-44A6-BDD8-CA34A0A5B479Q42844005-39C2D181-986D-4E68-B474-D013E885589EQ43165989-277CC923-84BE-4CC2-A12C-C70E93DFFB4FQ43280949-F61CEDDC-A7E7-420D-806D-79FC8C10F1FCQ43769843-B62D1A09-7BFD-447F-8417-2162C18324E8Q43782558-854DB24F-5F63-4D36-8C59-71CCD355D291Q44747451-3D7CE5AD-9BC1-49F3-9C67-1EF71CE349FFQ45009863-9FD7E94C-36AE-4F89-B9BF-31E179197FACQ51527259-0BD15FC2-B2A9-42A4-AFB2-706763C0005CQ51578777-719099DB-1CA8-47C6-8FAD-D1E279DC9153Q51622371-2CA8556B-55C4-4DEC-8B65-952AA94DA156Q51872132-9C2994E5-01C1-4378-9A5C-5A70C232C896Q53625862-B12537DF-D423-4B25-ABCD-8DD72EA779E0Q53919630-E8F8021E-AC22-46C0-9CFA-E15975E6FDF1Q57698678-184A818B-7310-412E-B549-0CC36DCD0C07Q58608413-4A20ADBB-BE32-49B7-AA15-5EEE4C35C331
P2860
Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@ast
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@en
type
label
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@ast
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@en
prefLabel
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@ast
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@en
P2093
P2860
P356
P1476
Helicobacter pylori gastritis ...... ic atrophy in high risk groups
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.144
P407
P577
1996-03-01T00:00:00Z